Menten AI

Menten AI is an innovative company specializing in the use of generative AI for the design of cyclic peptide therapeutics. Their proprietary platform, MAUD 1.0, is designed to create peptide macrocycles that possess drug-like properties, including oral bioavailability and cell permeability. This technology aims to address complex drug targets that are often beyond the capabilities of traditional small molecules and biologics, thereby unlocking the potential for new life-changing medicines.